Continuous Glucose Monitors (CGMs) have become essential tools for many people managing diabetes or monitoring blood sugar levels more closely. However, reliability and accuracy are critical features that users depend on to make informed health decisions. The experience shared here about the Lingo CGM highlights a real concern when devices fail to provide consistent data. It's important to understand why inaccuracies like those reported with the Lingo CGM matter so much. When a CGM provides flawed or inconsistent readings—such as showing averages in the high 80s when finger prick tests indicate otherwise—this can lead to mismanagement of insulin dosing or diet adjustments. Users may feel confused or anxious, especially if the device gives conflicting feedback about their blood sugar status. Many healthcare professionals recommend cross-checking CGM readings with traditional finger stick glucose tests to ensure accuracy. If discrepancies are frequent, the device should be recalibrated or replaced. As noted by some users, receiving a replacement monitor does not always resolve the issue, suggesting that device design, sensor quality, or calibration algorithms might be contributing factors. Transparency about device performance is essential. The phrase "NOT THIS CGM OF TRANSPARENCY" signals the need for manufacturers to offer clearer information regarding what users can realistically expect from their CGMs. This includes detailed data on accuracy levels, how often calibration is required, and potential reasons for measurement variations. For those considering CGMs, researching product reviews, consulting healthcare providers, and possibly testing different devices can help identify options that provide better reliability. Ultimately, the goal is to have a continuous monitoring system that enhances daily life and health management, not one that adds uncertainty. In summary, this user’s experience with the Lingo CGM underscores the importance of reliability in blood sugar monitoring technology. Patients and healthcare providers should be vigilant about the accuracy of CGMs and advocate for transparency and improvements in this essential technology.